MediSolution Ltd.
TSX : MSH

MediSolution Ltd.

May 25, 2006 09:00 ET

Pathology and Cytology Laboratories Inc. Selects MediSolution's Laboratory Information System to Improve Operational Efficiency

MONTREAL, QUEBEC--(CCNMatthews - May 25, 2006) -

New Integrated Solution to Increase Productivity and Improve Business Processes

MediSolution Ltd. (TSX:MSH), today announced that Pathology and Cytology Laboratories Inc (PCL), a full service laboratory offering a complete range of anatomical pathology services, has purchased MediLab, an automated laboratory information system (LIS) to increase laboratory efficiency. The system solution will improve the overall workflow and effectiveness of the lab and will allow PCL to enhance their service offering. The contract will be implemented over the next 12 months.

PCL will use MediLab, a comprehensive, high-performance LIS with Anatomical Pathology/Cytology and Financial modules, to automate various functions throughout their organization. The company will also leverage MediLab's extensive bar coding and imaging capabilities to enhance the services provided to their customers throughout central and western Kentucky.

"The selection of MediLab came after an extensive evaluation process" said Gladys Sizemore, Laboratory Administrator, PCL. "During our evaluation it became clear that the modular and scalable MediLab solution was the right choice to help us automate our business."

"Pathology and Cytology Laboratories joins our growing base of US Laboratory customers" said Paul Lepage, President and Chief Operating Officer, MediSolution Ltd. "Our comprehensive laboratory information system will enhance PCL's laboratory workflow while improving the delivery of services for their customers."

About Pathology and Cytology Laboratories Inc.

Pathology and Cytology Laboratories Inc., and Chipps, Caffrey and Dublier, PSC are specialists in Anatomic Pathology, Cytopathology, Hematopathology, Clinical Laboratory Consultation and Laboratory Medical Directorships. Founded in 1967, Pathology and Cytology Laboratories Inc., provides the highest quality service and professional expertise to physicians, clinics and hospitals. For more information, visit www.pandclab.com.

About MediSolution

MediSolution (TSX:MSH), a Brookfield Asset Management company, is a leading healthcare and public sector information technology company, providing software, solutions and services to customers across North America. More than 500 hospitals and other healthcare facilities and close to 200 public sector and related organizations rely on MediSolution's systems to maximize their operational efficiencies, lower their costs, and improve the delivery of services. MediSolution has two operating segments. The Resource Management Systems segment is comprised of Financial Management software such as accounts receivable, budgeting and materials management as well as Human Capital Management tools including human resource management, staff scheduling and payroll processing. The Healthcare Information Systems segment is comprised of clinical solutions such as patient tracking, electronic patient health records, pharmacy, radiology and laboratory software for healthcare organizations.

This press release contains "forward-looking statements" regarding MediSolution's MediLab product and its recent contract with Pathology and Cytology Laboratories Inc.. The words "will", "expect", "anticipate", "intend", "estimate" and other expressions which are predictions of or indicate future events and trends and which do not relate to historical matters identify forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements because they involve known an unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the company to differ materially from anticipated future results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those set forth in the forward-looking statements include delays in the implementation of the MediLab project, the cancellation of the contract and the laboratory information system product's failure to generate anticipated business efficiencies for the client.

Contact Information